Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Biosimilars: SOP for In-Process Sampling Procedures in Bioreactor Operations – V 2.0

Posted on By


Biosimilars: SOP for In-Process Sampling Procedures in Bioreactor Operations – V 2.0


Standard Operating Procedure for In-Process Sampling Procedures in Bioreactor Operations for Biosimilars

Department Biosimilars
SOP No. SOP/BS/078/2025
Supersedes SOP/BS/078/2022
Page No. Page 1 of 11
Issue Date 04/05/2025
Effective Date 06/05/2025
Review Date 04/05/2026

1. Purpose

To define the standardized method for aseptic in-process sampling from bioreactors used in biosimilar production. This SOP ensures representative, contaminant-free samples for analysis of critical process parameters.

2. Scope

This SOP applies to all stainless steel and single-use bioreactor systems used in upstream biosimilar manufacturing for sampling culture media, cells, metabolites, and gases.

3. Responsibilities

  • Bioprocess Technicians: Perform in-process sampling and record data.
  • QC Analysts: Analyze collected samples for cell count, viability, pH, metabolites, etc.
  • QA Officer: Verify logbook entries and confirm sampling frequencies.

4. Accountability

The Upstream Production Manager is accountable for ensuring in-process sampling is performed aseptically and results are promptly reviewed.

5. Procedure

5.1 Sampling Frequency

  1. Follow the sampling schedule as per the approved Batch Manufacturing Record (BMR).
  2. Typical sampling intervals:
    • Every 12 hours during the batch phase
    • Every 8 hours during the feeding phase
    • Every 4 hours near harvest phase

5.2 Preparation

  1. Ensure all sampling accessories are sterile (syringes, sample bags, tubes).
  2. Wipe sampling ports with 70% IPA and ensure sterile gloves and gowning.
  3. Label sample containers with:
    • Batch No.
    • Date and Time
    • Sample Type

5.3 Sampling Technique

  1. Connect sampling line or septum port to a sterile syringe or sampling valve.
  2. Discard the first 2–5 mL to remove stagnant fluid (flush step).
  3. Collect the required volume (typically 10–20 mL) without introducing air bubbles.
  4. Seal sample container immediately and transfer to QC or store at 2–8°C until analysis.

5.4 Post Sampling

  1. Disinfect sampling port again with 70% IPA and close securely.
  2. Dispose of used syringes and gloves as per biohazard SOPs.
  3. Record the sampling details in the Bioreactor Sampling Log (Annexure-1).

5.5 Sample Handling and Transfer

  1. Transport samples in designated clean containers to QC within 30 minutes of collection.
  2. Log handover with time and recipient signature in Sample Transfer Log (Annexure-2).

6. Abbreviations

  • BMR: Batch Manufacturing Record
  • QC: Quality Control
  • IPA: Isopropyl Alcohol

7. Documents

  1. Bioreactor Sampling Log – Annexure-1
  2. Sample Transfer Log – Annexure-2

8. References

  • ICH Q9 – Quality Risk Management
  • WHO TRS 999 – GMP for Biological Products

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Bioreactor Sampling Log

Date Time Batch No. Sample Type Volume (mL) Collected By Remarks
04/05/2025 08:00 BS-BR-078 Viability 15 Rajesh Kumar Normal

Annexure-2: Sample Transfer Log

Date Time Sample ID Transferred To Signature
04/05/2025 08:15 BS-078-08V Sunita Reddy SR

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
04/05/2025 2.0 Updated sample handling and transfer timelines GMP Compliance
See also  Biosimilars: SOP for Alarms and Alerts Handling During Culture - V 2.0
Biosimilars V 2.0 Tags:biosimilar manufacturing SOP, biosimilar process validation SOP, biosimilar quality control procedure, cell line development SOP biosimilars, chromatography SOP biosimilars, cleaning validation SOP for biosimilar equipment, cleanroom SOP for biologics manufacturing, deviation handling SOP in bioprocess, downstream processing SOP, environmental monitoring SOP biosimilars, GMP SOP for biosimilars, host cell protein removal SOP, inline UV monitoring SOP biosimilars, media preparation SOP for biosimilars, protein purification SOP, purification skid calibration SOP, SOP for bioreactor inoculation biosimilars, SOP for biosimilar cell banking, SOP for cell culture in biosimilar production, SOP for chromatography column packing, SOP for ELISA-based clone screening, SOP for endotoxin testing in biologics, SOP for filter sterilization in downstream processing, SOP for glycosylation analysis in biosimilars, SOP for master cell bank, SOP for protein A chromatography steps, SOP for resin qualification in biosimilar purification, SOP for viral clearance in biosimilar production, SOP for working cell bank, upstream processing SOP biosimilars

Post navigation

Previous Post: Gel Manufacturing: SOP for Bulk Storage of Gels – V 2.0
Next Post: Aerosol: SOP for Archiving Analytical Test Results – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version